This clinical trial is focused on studying the prevention of influenza infection in older adults. The study compares two types of vaccines: a high-dose quadrivalent influenza vaccine and a standard-dose quadrivalent influenza vaccine. Quadrivalent vaccines are designed to protect against four different strains of the influenza virus. The high-dose vaccine is intended to provide a stronger immune response, which may be particularly beneficial for older adults who are at higher risk of complications from influenza.
The purpose of the study is to evaluate how effective the high-dose vaccine is compared to the standard-dose vaccine in reducing the risk of hospitalization due to influenza or pneumonia. Pneumonia is a lung infection that can be a serious complication of influenza, especially in older adults. Participants in the study will receive either the high-dose or standard-dose vaccine through an intramuscular injection, which means the vaccine is given as a shot into a muscle.
Throughout the study, researchers will monitor participants to see if they are hospitalized for influenza, pneumonia, or any other cardio-respiratory diseases, which affect the heart and lungs. They will also track all-cause hospitalizations and mortality. The study aims to provide valuable information on which vaccine might offer better protection for older adults, ultimately helping to guide future vaccination strategies for this age group.



Denmark